JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clancy, B. M.
Right arrow Articles by Czech, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clancy, B. M.
Right arrow Articles by Czech, M. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 16, 10122-10130, Jun, 1991

Protein synthesis inhibitors activate glucose transport without increasing plasma membrane glucose transporters in 3T3-L1 adipocytes

BM Clancy, SA Harrison, JM Buxton and MP Czech
Program in Molecular Medicine, University of Massachusetts Medical Center, Worcester 01605.

In this study, we tested the hypothesis that hexose transport regulation may involve proteins with relatively rapid turnover rates. 3T3-L1 adipocytes, which exhibit 10-fold increases in hexose transport rates within 30 min of the addition of 100 nM insulin, were utilized. Exposure of these cells to 300 microM anisomycin or 500 microM cycloheximide caused a maximal, 7-fold increase in 2-deoxyglucose transport rate after 4-8 h. The effects due to either insulin (0.5 h) or anisomycin (5 h) on the kinetics of zero-trans 3-O- methyl[14C]glucose transport were similar, resulting in 2.5-3-fold increases in apparent Vmax values (control Vmax = 1.6 +/- 0.3 x 10(-7) mmol/s/10(6) cells) coupled with approximately 2-fold decreases in apparent Km values (control Km = 23 +/- 3.3 mM). Insulin elicited the expected increases in plasma membrane levels of HepG2/erythrocyte (GLUT1) and muscle/adipocyte (GLUT4) transporters (1.6- and 2.8-fold, respectively) as determined by protein immunoblotting. In contrast, neither total cellular contents nor plasma membrane levels of these two transporter isoforms were increased when 3T3-L1 adipocytes were treated with either anisomycin or cycloheximide. 3-[125I]Iodo-4- azidophenethylamido-7-O-succinyldeacetylforskoli n labeling of glucose transporters in plasma membrane fractions of similarly treated cells was also unaffected by these agents. Thus, a striking discrepancy was observed between the marked increase in cellular hexose transport rates due to these protein synthesis inhibitors and the unaltered amounts of glucose transporter proteins in the plasma membrane fraction. These data indicate that short-term protein synthesis inhibition in 3T3-L1 adipocytes leads to large increases in the intrinsic catalytic activity of one or both of the GLUT1 and GLUT4 transporter isoforms.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Konstantopoulos, S. Marcuccio, S. Kyi, V. Stoichevska, L. A. Castelli, C. W. Ward, and S. L. Macaulay
A Purine Analog Kinase Inhibitor, Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor 59, Reveals a Role for Calcium/Calmodulin-Dependent Protein Kinase II in Insulin-Stimulated Glucose Transport
Endocrinology, January 1, 2007; 148(1): 374 - 385.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
O. S. Dallner, E. Chernogubova, K. A. Brolinson, and T. Bengtsson
{beta}3-Adrenergic Receptors Stimulate Glucose Uptake in Brown Adipocytes by Two Mechanisms Independently of Glucose Transporter 4 Translocation
Endocrinology, December 1, 2006; 147(12): 5730 - 5739.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Renstrom, J. Buren, and J. W. Eriksson
Insulin Receptor Substrates-1 and -2 Are Both Depleted but via Different Mechanisms after Down-Regulation of Glucose Transport in Rat Adipocytes
Endocrinology, July 1, 2005; 146(7): 3044 - 3051.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Wang, M. Tonouchi, D. Miskovic, H. Hatta, and A. Bonen
T3 increases lactate transport and the expression of MCT4, but not MCT1, in rat skeletal muscle
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E622 - E628.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
N. Kumar and C. S. Dey
Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells
J. Exp. Biol., December 1, 2002; 205(23): 3739 - 3746.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Maresca, R. Mahfoud, N. Garmy, and J. Fantini
The Mycotoxin Deoxynivalenol Affects Nutrient Absorption in Human Intestinal Epithelial Cells
J. Nutr., September 1, 2002; 132(9): 2723 - 2731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Somwar, W. Niu, D. Y. Kim, G. Sweeney, V. K. Randhawa, C. Huang, T. Ramlal, and A. Klip
Differential Effects of Phosphatidylinositol 3-Kinase Inhibition on Intracellular Signals Regulating GLUT4 Translocation and Glucose Transport
J. Biol. Chem., November 30, 2001; 276(49): 46079 - 46087.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Konrad, R. Somwar, G. Sweeney, K. Yaworsky, M. Hayashi, T. Ramlal, and A. Klip
The Antihyperglycemic Drug {alpha}-Lipoic Acid Stimulates Glucose Uptake via Both GLUT4 Translocation and GLUT4 Activation: Potential Role of p38 Mitogen-Activated Protein Kinase in GLUT4 Activation
Diabetes, June 1, 2001; 50(6): 1464 - 1471.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
I. I. Budihardjo, S. A. Boerner, S. Eckdahl, P. A. Svingen, R. Rios, M. M. Ames, and S. H. Kaufmann
Effect of 6-Aminonicotinamide and Other Protein Synthesis Inhibitors on Formation of Platinum-DNA Adducts and Cisplatin Sensitivity
Mol. Pharmacol., March 1, 2000; 57(3): 529 - 538.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Subtil, M. A Lampson, S. R. Keller, and T. E. McGraw
Characterization of the Insulin-regulated Endocytic Recycling Mechanism in 3T3-L1 Adipocytes Using a Novel Reporter Molecule
J. Biol. Chem., February 18, 2000; 275(7): 4787 - 4795.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. F. Hausdorff, D. C. Fingar, K. Morioka, L. A. Garza, E. L. Whiteman, S. A. Summers, and M. J. Birnbaum
Identification of Wortmannin-sensitive Targets in 3T3-L1 Adipocytes. DISSOCIATION OF INSULIN-STIMULATED GLUCOSE UPTAKE AND GLUT4 TRANSLOCATION
J. Biol. Chem., August 27, 1999; 274(35): 24677 - 24684.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. C. Bunn, M. A. Jensen, and B. C. Reed
Protein Interactions with the Glucose Transporter Binding Protein That Provide a Link between GLUT1 and the Cytoskeleton
Mol. Biol. Cell, April 1, 1999; 10(4): 819 - 832.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. VanRenterghem, M. Morin, M. P. Czech, and R. A. Heller-Harrison
Interaction of Insulin Receptor Substrate-1 with the sigma 3A Subunit of the Adaptor Protein Complex-3 in Cultured Adipocytes
J. Biol. Chem., November 6, 1998; 273(45): 29942 - 29949.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Hansen, W. Wang, B. A. Marshall, J. O. Holloszy, and M. Mueckler
Dissociation of GLUT4 Translocation and Insulin-stimulated Glucose Transport in Transgenic Mice Overexpressing GLUT1 in Skeletal Muscle
J. Biol. Chem., July 17, 1998; 273(29): 18173 - 18179.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Van Epps-Fung, J. Williford, A. Wells, and R. W. Hardy
Fatty Acid-Induced Insulin Resistance in Adipocytes
Endocrinology, October 1, 1997; 138(10): 4338 - 4345.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. D. McCoy, N. Ahmed, A. S. Tan, and M. V. Berridge
The Hemopoietic Growth Factor, Interleukin-3, Promotes Glucose Transport by Increasing the Specific Activity and Maintaining the Affinity for Glucose of Plasma Membrane Glucose Transporters
J. Biol. Chem., July 11, 1997; 272(28): 17276 - 17282.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Heller-Harrison, M. Morin, A. Guilherme, and M. P. Czech
Insulin-mediated Targeting of Phosphatidylinositol 3-Kinase to GLUT4-containing Vesicles
J. Biol. Chem., April 26, 1996; 271(17): 10200 - 10204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lachaal, A. L. Rampal, W. Lee, Y.-w. Shi, and C. Y. Jung
GLUT1 Transmembrane Glucose Pathway
J. Biol. Chem., March 1, 1996; 271(9): 5225 - 5230.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Heller-Harrison, M. Morin, and M. P. Czech
Insulin Regulation of Membrane-associated Insulin Receptor Substrate 1
J. Biol. Chem., October 13, 1995; 270(41): 24442 - 24450.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Volchuk, R. Sargeant, S. Sumitani, Z. Liu, L. He, and A. Klip
Cellubrevin Is a Resident Protein of Insulin-sensitive GLUT4 Glucose Transporter Vesicles in 3T3-L1 Adipocytes
J. Biol. Chem., April 7, 1995; 270(14): 8233 - 8240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Nugent, J. B. Prins, J. P. Whitehead, J. M. Wentworth, V. K. K. Chatterjee, and S. O'Rahilly
Arachidonic Acid Stimulates Glucose Uptake in 3T3-L1 Adipocytes by Increasing GLUT1 and GLUT4 Levels at the Plasma Membrane. EVIDENCE FOR INVOLVEMENT OF LIPOXYGENASE METABOLITES AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma
J. Biol. Chem., March 16, 2001; 276(12): 9149 - 9157.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Tonouchi, H. Hatta, and A. Bonen
Muscle contraction increases lactate transport while reducing sarcolemmal MCT4, but not MCT1
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1062 - E1069.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.